Additional Information from Parental Questionnaires and Pharmacy Records for Registration of Birth Defects

EUROCAT Northern Netherlands registers children born with a birth defect in the Northern Netherlands. Data used to be collected via a notification form, which is filled out by the notifier and, if necessary, completed by the general practitioner. To increase the amount of information, EUROCAT starte...

Full description

Saved in:
Bibliographic Details
Published in:European journal of epidemiology 2000-04, Vol.16 (4), p.329-336
Main Authors: Reefhuis, J., de Walle, H. E. K., de Jong-van den Berg, L. T. W., Cornel, M. C., Euro MAP-Group
Format: Article
Language:English
Subjects:
Babies
Biological and medical sciences
Birth defects
Congenital anomalies
Consent
Data collection
Drug stores
Drug toxicity and drugs side effects treatment
Drug use
Epidemiology
Ethnicity
Family physicians
Medical personnel
Medical sciences
Methods
Midwifery
Miscellaneous (drug allergy, mutagens, teratogens...)
Neonatal disorders
Parents
Pharmacies
Pharmacists
Pharmacology. Drug treatments
Physicians
Pregnancy
Professionals
Questionnaires
Registration
Risk factors
Telephone interviews
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:EUROCAT Northern Netherlands registers children born with a birth defect in the Northern Netherlands. Data used to be collected via a notification form, which is filled out by the notifier and, if necessary, completed by the general practitioner. To increase the amount of information, EUROCAT started using new methodology in July 1997. The new procedure consists of three additional steps. Firstly, a parental questionnaire with 43 questions concerning pregnancy and medical history is sent to the parents. Also, the pharmacist is approached to provide information on the drugs that were dispensed to the mother in the period from three months before until the end of the pregnancy. The last step is a telephone interview with the mother. In this study the old and new method are compared with respect to response, quality and quantity of the data. Of the 198 parental questionnaires included in this study, 179 (90.4%) were returned. The pharmacists returned 173 out of 179 requests for information (96.6%). The parental information is more complete for ethnicity and serum screening. The quality of the drug exposure data is much better using the new methodology. The general practitioner's input is still necessary for specification and verification of the diagnosis.
ISSN:0393-2990
1573-7284
DOI:10.1023/A:1007656619529